Company Quick10K Filing
Cray
10-Q 2019-06-30 Filed 2019-08-02
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-02-12
10-Q 2018-09-30 Filed 2018-10-30
10-Q 2018-06-30 Filed 2018-07-31
10-Q 2018-03-31 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-15
10-Q 2017-09-30 Filed 2017-10-30
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-05-02
10-K 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-05-03
10-K 2015-12-31 Filed 2016-02-11
10-Q 2015-09-30 Filed 2015-10-29
10-Q 2015-06-30 Filed 2015-07-30
10-Q 2015-03-31 Filed 2015-05-05
10-K 2014-12-31 Filed 2015-02-19
10-Q 2014-09-30 Filed 2014-10-28
10-Q 2014-06-30 Filed 2014-07-29
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-07-31
10-K 2012-12-31 Filed 2013-02-28
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-07-31
10-Q 2012-03-31 Filed 2012-04-26
10-K 2011-12-31 Filed 2012-02-27
10-Q 2011-09-30 Filed 2011-11-01
10-Q 2011-06-30 Filed 2011-07-28
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-04
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-16
8-K 2019-09-25
8-K 2019-09-20
8-K 2019-08-27
8-K 2019-08-16
8-K 2019-08-13
8-K 2019-08-02
8-K 2019-06-23
8-K 2019-06-11
8-K 2019-05-16
8-K 2019-05-07
8-K 2019-05-07
8-K 2019-02-20
8-K 2019-02-12
8-K 2019-01-14
8-K 2018-10-30
8-K 2018-07-31
8-K 2018-06-12
8-K 2018-05-01
8-K 2018-04-20
8-K 2018-02-15
8-K 2018-01-16

Cray Financials

CRAY Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash1328850109219228253165149571931881218311311968190267294213144223198171152137137144184246222165
Accounts Receivable2026726410222135925451835977451658113714312560561101985575631629611375886677
Inventory48959812113216990791262069511819219814421022123011412219724488114156198186181148142808188
PP&E17171616172110926272712431313194343532102313028903837381023738361123638
Assets245256283351512535510476503501603576606543651644660768694689696723715669701667619541520506517500460
Accounts Payable235138553761353362573436764349617870284672664631564257221729332530
Long-Term Debt
Liabilities103122116178185210170138164178228210248168198191202300202181197245189160198173218162149156174183183
Stockholders' Equity142134167173327324341338338323376366359376454453458468493508500478525509503494400379371350343318276
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue6837921121603618980128543075586159262801861912671061007734759878016780120931637269
Cost of Revenue4220566796181355595341943756111173561371261816664542263559511175382681234645
Gross Profit26163545631754242720113182949892450668640362412024282850273825402624
R&D181872423242325222025292627293033172722302926303637
SG&A101011131810201719162517192125192023272324232823222023212122242031
Tax0004420210-01100147101-2-5111-4-710200001
Net Income-3-12315165-514-8-0-1151-13-7775-961120-5-13-2352-19-7-10-98-25-11-22-13-29-43
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-42-3758-326170-726-1088761-63-6693-421077934-94-738170-28-80-35-1141-21-51
Cash Investing-1-1-0138-53-46-17-221749-67-329182-717-4-9147-3-9626119-16-0-4-4
Cash Financing0115111-1-101-1-0100-312-1-200-1001-2-01-2